Cite Filings / ORMP / 0001012975-25-000992

Feed Companies Filings Check

Sign in

8-K

Current Report

ORAMED PHARMACEUTICALS INC. Filed 2025-12-31 Acc 0001012975-25-000992

Other events

Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

8-K Current Report , ormp-20251230.htm

Around this filing

2026-01-05 4 Director acquired 36,250 shares (grant or award)
2026-01-05 4 President and CEO acquired 559,640 shares (grant or award)
2026-01-02 4 Director acquired 36,250 shares (grant or award)
2026-01-02 4 Chief Financial Officer acquired 196,216 shares (grant or award)
2025-12-31 8-K Executive or director change
2025-12-31 8-K Other events
2025-11-17 8-K Results of operations

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading ormp-20251230.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…